2016
Incidence and predictors of bleeding complications after percutaneous coronary intervention
Numasawa Y, Kohsaka S, Ueda I, Miyata H, Sawano M, Kawamura A, Noma S, Suzuki M, Nakagawa S, Momiyama Y, Fukuda K. Incidence and predictors of bleeding complications after percutaneous coronary intervention. Journal Of Cardiology 2016, 69: 272-279. PMID: 27269413, DOI: 10.1016/j.jjcc.2016.05.003.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionPrevious percutaneous coronary interventionClinical presentationCoronary interventionPatient characteristicsIndependent predictorsTransradial interventionIntra-aortic balloon pumpingMultivariate logistic regression analysisMulticenter PCI registryPrevious heart failureElevation myocardial infarctionUse of antiplateletPatient's clinical presentationChronic total occlusionLogistic regression analysisRisk prediction modelRegistry criteriaCardiogenic shockPCI patientsPCI registryConsecutive patientsHeart failureBalloon pumpingST elevation
2009
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial
Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, Velazquez EJ, Califf RM, Scheiman JM, Solomon SD. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. European Heart Journal 2009, 30: 2226-2232. PMID: 19556260, DOI: 10.1093/eurheartj/ehp256.Peer-Reviewed Original ResearchConceptsRisk factorsGastrointestinal bleedingGI bleedingWorse New York Heart Association classNew York Heart Association classAcute Myocardial Infarction trialPost-myocardial infarction patientsAdditional antiplatelet drugsProfound risk factorRate of GIAdjusted hazard ratioDual antiplatelet therapyMultivariable Cox modelMyocardial Infarction trialDual antiplatelet agentsLeft ventricular dysfunctionGlomerular filtration rateHigh-risk survivorsUse of antiplateletPost-MI patientsRisk of deathPotential risk factorsNon-white racePresent secondary analysisOccurrence of GI
2000
Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease
Kornowski R, Lansky A. Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease. Catheterization And Cardiovascular Interventions 2000, 50: 245-254. PMID: 10842400, DOI: 10.1002/(sici)1522-726x(200006)50:2<245::aid-ccd22>3.0.co;2-p.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseCoronary interventionBypass surgeryArtery diseaseDiabetes mellitusDiabetic patientsClinical outcomesCoronary artery bypass surgeryDiffuse coronary artery diseaseCatheter-based coronary interventionsArtery bypass surgeryCoronary bypass surgeryInterventional treatment strategiesPercutaneous coronary interventionUse of antiplateletAtherosclerosis lesion progressionTarget vessel sizeAdjunctive pharmacologyMore restenosisMultivessel diseaseAtherosclerosis burdenCoronary atherosclerosisCoronary proceduresCoronary sitesAdjunctive pharmacotherapy
1997
Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease
Schussheim A, Fuster V. Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease. Progress In Cardiovascular Diseases 1997, 40: 205-238. PMID: 9406677, DOI: 10.1016/s0033-0620(97)80035-7.Peer-Reviewed Original ResearchConceptsThrombus formationAntithrombotic agentsAnticoagulant agentsCardiac diseaseUse of antiplateletUnderstanding of pathogenesisRational approachAntithrombotic therapyAntithrombotic approachAntiplatelet agentsConcomitant useDisease entityRelative riskHigh riskLower riskThrombosisHemostatic processAntiplateletAntithromboticsRiskDiseaseMedium riskAgentsThromboembolismAnticoagulants
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply